Switch to:
More From Other Websites
Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash... Jun 21 2016
Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash... Jun 21 2016
ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Jun 21 2016
Zogenix Announces Initiation of Multi-National Phase 3 Clinical Trial for ZX008 in Dravet Syndrome Jun 07 2016
ZOGENIX, INC. Files SEC form 8-K, Other Events Jun 07 2016
Zogenix Announces Initiation of Multi-National Phase 3 Clinical Trial for ZX008 in Dravet Syndrome Jun 07 2016
Zogenix to Participate in Jefferies 2016 Healthcare Conference May 31 2016
Zogenix to Participate in Jefferies 2016 Healthcare Conference May 31 2016
ETF’s with exposure to Zogenix, Inc. : May 24, 2016 May 24 2016
Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 May 23 2016
ZOGENIX, INC. Financials May 19 2016
Zogenix reports 1Q loss May 10 2016
Zogenix reports 1Q loss May 10 2016
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 10 2016
Zogenix Provides Corporate Update and Reports First Quarter 2016 Financial Results May 10 2016
Zogenix Provides Corporate Update and Reports First Quarter 2016 Financial Results May 10 2016
Q1 2016 Zogenix Inc Earnings Release - After Market Close May 10 2016
ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement May 05 2016
Zogenix Announces New Efficacy and Safety Data on ZX008 for Treatment of Seizures in Dravet Syndrome May 05 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK